Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Galapagos Nv (NASDAQ: GLPG)

$84.86 USD -$0.95 (-1.11%)
Last Price $84.86
Net Change $-0.95 (-1.11%)
Bid $0
Ask Price $0
Open Price $85.57
Previous Close Price $85.81
High Price $85.8
Low Price $84.24
Number of Trades 922
Volume 171,656
Fifty Two Week High $94.88 (2017-04-17)
Fifty Two Week Low $49.43 (2016-06-27)
Average Daily Volume 144,571
Share Outstanding 50,820 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $1707.6
EPS Growth $-294.35
Recent Earnings $
Annual EPS $0.05
Last Quarter EPS $
Market Capitalization $4.31B
Insider Shareholders % 0%
Annual Revenue $0B
No. Shares Outstanding 50,820
Inst. Shareholder % 19.87%
Annual Net Income $0B
TTM Net Profit Margin $1.79
1-Year Return 50.7%
3-Year Return 304.57%
5-Year Return 483.74%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -294.350006%
Dividends per Share $
Stock Split Ratio
Beta 1.8
Galapagos NV is a biotechnology company. The Company's operating segment consists of Research and Development and Services. Research and Development segment is engaged in the discovery and development of small molecules. Services segment offers drug discovery products and services. Its products include GLPG0634 for the treatment of rheumatoid arthritis and other inflammatory diseases, GLPG1205/GLPG1690 for treating inflammatory bowel disease, GSK2586184 for the treatment of chronic immuno-inflammatory diseases and GLPG0974, to prevent free fatty acid-induced activation and migration of neutrophils which are in different clinical trial. Galapagos NV is headquartered in Mechelen, Belgium.